Previous 10 | Next 10 |
home / stock / hls:cc / hls:cc news
HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference Canada NewsWire TORONTO , Sept. 6, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS"...
HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results Canada NewsWire TORONTO , Aug. 10, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular mark...
HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Aug. 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 Fiscal 2023 financial results on Thursday, ...
HLS Therapeutics Announces Updates to its Board of Directors Canada NewsWire John Welborn, Jr. is appointed Chair of the Board, succeeding Greg Gubitz , who is retiring John Hanna is appointed to the HLS Board as an independent director ...
HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors Canada NewsWire HLS Directors J. Spencer Lanthier and Don DeGolyer will not be standing for re-election at the 2023 AGM ...
HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results Canada NewsWire TORONTO , May 11, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular markets, a...
HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , May 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 Fiscal 2023 financial results on Thursday, M...
HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference HLS Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire TORONTO , April 21, 2023 /CNW/ - HLS Therapeutics Inc. ...
HLS Therapeutics Announces CEO Transition Canada NewsWire • Craig Millian to replace retiring CEO, Gilbert Godin , on May 1, 2023 TORONTO , April 17, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company...
HLS Therapeutics Announces Q4 and Fiscal 2022 Financial Results Canada NewsWire TORONTO , March 16, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular...
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc. Company Name:
HLS:CC Stock Symbol:
TSXC Market:
HLS Therapeutics Inc. Website:
HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust Canada NewsWire Total consideration of up to $45.75 million , which consists of upfront cash, sales-based milestone payments and DRI Healthcare's assumption of future mi...
A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.5% to $3.36 on volume of 12,209,225 shares Solstice Gold Corp. (SGC) fell 33.3% to $0.02 on volume of 11,588,936 shares HIGH INTEREST SAVINGS ACCOUNT FUND (HISA) fell 0.3% to $50.01 on volume of 10,628,355 shares ...
Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...